Avalon HepaPOC

Avalon HepaPOC is a biotechnology company focused on the development and commercialization of point-of-care (POC) diagnostic devices for liver health. A subsidiary of Avalon GloboCare, the company's flagship product is the HepaPOC system, which provides rapid, quantitative detection of liver enzymes such as AST and ALT from a finger-stick blood sample. This technology is designed to facilitate early screening and monitoring of chronic liver diseases, including Hepatitis B, Hepatitis C, and nonalcoholic steatohepatitis (NASH). By enabling real-time results in clinical and field settings, Avalon HepaPOC aims to improve patient management and reduce the global burden of liver-related morbidity.